Identification of Normal Vs. Potentially Precancerous Prostate Lesions

Organization:University of Pittsburgh, Pa, US
I.P. Brief:Our study with fifteen-Lipoxygenase type 1 (15-LO-1, ALOX15) gene suggests that we can distinguish precancerous lesions from benign lesions by assaying for a specific change in 15-LO-1 promoter DNA methylation status.
Keywords:diagnostic, markers, prostate cancer
Primary Industry:Pharma & Biotech
Specific Market:Prostate Cancer Markers

Full IP Descriptions available on-site.


Corporate Presentations:

  • Air Products
  • BASF
  • Eastman Kodak Company
  • Genzyme
  • Goodrich
  • Hewlett-Packard
  • Honda
  • Medtronic
  • Merck
  • Sanyo

Reserved Presentations:

  • ExxonMobil
  • IBM

Partnering Events:
(full access included)

Platinum Sponsor

University of Hawaii

Press Sponsor

Business Wire

Commercialization Partner



Invest Australia AzTE Technology Enterprises

Media Sponsors

(joint with Nanotech 2007) Nature
Red Herring

Supporting Organizations

Boston University
Midwest Research University Network


“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
Matthew Laudon, Co-Founder and Director of TechConnect